Raf inhibitor compounds

US9187474B2 · kind B2 · utility

Assignees

• Deciphera Pharmaceuticals, LLC · US
• ELI LILLY AND COMPANY · US

Inventors

• Daniel L. Flynn · Lawrence, US
• Michael D. Kaufman · Waltham, US
• Lakshminarayana Vogeti · Lawrence, US
• Scott Wise · Lawrence, US
• Wei Lu · Newton, US
• Bryan D. Smith · Madison, US
• Timothy Caldwell · Fishers, US
• William C. Patt · Chelsea, US
• James Robert Henry · Indianapolis, US
• Philip Arthur Hipskind · New Palestine, US
• Sheng-Bin Peng · Carmel, US

Key dates

• Filing date: Mar 5, 2013
• Grant date: Nov 17, 2015
• Expiry date: Mar 5, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

This invention provides compounds of Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I); and use of a compound of Formula (I) for treating specified cancers.